Ensign Peak Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Sell |
59,018
-3,348
| -5% | -$184K | 0.01% | 742 |
|
|
2025
Q1 | $4.41M | Buy |
62,366
+498
| +0.8% | +$35.2K | 0.01% | 665 |
|
|
2024
Q4 | $4.07M | Sell |
61,868
-5,995
| -9% | -$394K | 0.01% | 699 |
|
|
2024
Q3 | $4.77M | Sell |
67,863
-4,025
| -6% | -$283K | 0.01% | 638 |
|
|
2024
Q2 | $5.92M | Sell |
71,888
-280
| -0.4% | -$23.1K | 0.01% | 581 |
|
|
2024
Q1 | $6.3M | Sell |
72,168
-85,808
| -54% | -$7.49M | 0.01% | 566 |
|
|
2023
Q4 | $15.2M | Buy |
157,976
+38,095
| +32% | +$3.67M | 0.03% | 342 |
|
|
2023
Q3 | $10.6M | Sell |
119,881
-2,070
| -2% | -$183K | 0.02% | 376 |
|
|
2023
Q2 | $10.6M | Buy |
121,951
+16,252
| +15% | +$1.41M | 0.02% | 404 |
|
|
2023
Q1 | $10.3M | Sell |
105,699
-136,402
| -56% | -$13.3M | 0.02% | 406 |
|
|
2022
Q4 | $25.1M | Buy |
242,101
+22,529
| +10% | +$2.33M | 0.06% | 260 |
|
|
2022
Q3 | $18.6M | Buy |
219,572
+129,246
| +143% | +$11M | 0.05% | 283 |
|
|
2022
Q2 | $7.49M | Buy |
90,326
+44,936
| +99% | +$3.72M | 0.02% | 427 |
|
|
2022
Q1 | $3.5M | Sell |
45,390
-7,800
| -15% | -$601K | 0.01% | 688 |
|
|
2021
Q4 | $4.7M | Buy |
+53,190
| New | +$4.7M | 0.01% | 682 |
|
|
2020
Q4 | – | Sell |
-16,459
| Closed | -$1.25M | – | 1857 |
|
|
2020
Q3 | $1.25M | Buy |
+16,459
| New | +$1.25M | ﹤0.01% | 1207 |
|
|
2020
Q1 | – | Sell |
-10,550
| Closed | -$892K | – | 1630 |
|
|
2019
Q4 | $892K | Buy |
+10,550
| New | +$892K | ﹤0.01% | 1372 |
|